Navigation Links
Alfalight receives $7 million in expansion funding

Madison, Wis. - Alfalight, Inc., a manufacturer of diode lasers for industrial, defense, and telecommunications markets worldwide, has received $7 million in expansion funding, the company reported on Wednesday.

The financing package was led by GF Private Equity Group, LLC and included all of Alfalight's major previous investors. Those includ......

Full article >>> diode performance and recently qualified for additional funding from the Defense Advanced Research Projects Agency (DARPA).

"This additional funding is a vote of confidence in our technology, products and execution capabilities by the investment community," said Warrior.

"Alfalight has proved its dedication to successfully commercializing innovative laser diode technologies," sa......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/18/05


Related biology technology :

1. Alfalight awarded $1.7M from Army Research Lab
2. Alfalight receives $4.7M to produce next generation lasers
3. Nair joins Alfalight; Prill coming to Journal Sentinel interactive media
4. Alfalight introduces new 25-watt pump module
5. Alfalight awarded $4.5 million Army Research contract
6. Alfalight garners $1.4 million defense funding for diode program
7. Alfalight finds Chinese distributor for high-power lasers
8. Alfalight receives $3.8 million Air Force laser contract
9. Alfalight increases laser efficiency for DOD program
10. Alfalight Appoints New President and CEO
11. Alfalight Packages 20-Watt Combined Power Module
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):